Shared your frustration for 2 years.
Bailed last month after realising I can make better money on CCE, product actually to market, quality of management etc.
EIF have good prospects, but have a while to go on sales yet. Also the first usage of the product, which was targeting insulin deployment looks like its been beaten to the punch with a US inhaler under trial. Having written to the company for explanation/clarification, the qstn. falls into a black hole with no response!
Good luck.
EIF
eiffel technologies limited
